Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07514117 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electroacupuncture With Two Pulse Patterns for Bell's Palsy Using Surface Electromyography Evaluation

Study acronym: EABP-SEMG
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint removed 2 → 1 primary endpoints
See other at-risk trials from The First Affiliated Hospital of Zhejiang Chinese Medical University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
    • Start date: May 2026 to Sep 2026
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: 3 to 4
    v4
  2. Primary completion pushed from Dec 2026 to Oct 2027
    • Study completion pushed from Feb 2027 to Dec 2027
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial is designed to evaluate the therapeutic effects of two EA parameter settings for Bell's palsy and to investigate the electromyographic characteristics of the disease. The main questions it aims to answer are: * Can continuous pulse pattern and intermittent pulse pattern of EA improve the symptoms of Bell's palsy? * Do continuous pulse pattern and intermittent pulse pattern of EA impact the electromyographic characteristics of facial muscles in patients with Bell's palsy? The researchers will evaluate the effects of continuous pulse pattern and intermittent pulse pattern in treating Bell's palsy by using surface electromyography as an objective indicator of assessment. The trial lasts for 4 weeks and the treatment period lasts for 4 weeks. Participants will: * receive sham EA, EA with a continuous pulse pattern or EA with an intermittent pulse pattern for 3 times weekly for 4 weeks (12 sessions in total). * receive assessment of symptom severity and social functioning on Day 0, end of week 2, end of week 4 and 6 months after the disease onset.
Trial Details
NCT Number NCT07514117
Lead Sponsor The First Affiliated Hospital of Zhejiang Chinese Medical University
Collaborators: The Third Affiliated hospital of Zhejiang Chinese Medical University
Conditions
(from sponsor)		 Bell Palsy
Related terms Bell Palsy
Enrollment 111 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov